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Abstact
Background: The inorganic phosphate (Pi) transporter, PiT1 (SLC20A1), is ubiquitously expressed in mammalian
cells. It has previously been shown that down-regulation of PiT1 severely impaired the proliferation of two
transformed human cells lines, HepG2 and HeLa, and the tumorigenicity of HeLa cells in nude mice. Moreover, PiT1
knock-out mice do not survive past E12.5 and from E10.5, the embryos were found to be growth-retarded and
showed reduced proliferation of liver cells. Isolated mouse embryonic fibroblasts with knocked out as well as
reduced PiT1 expression levels also exhibited impaired proliferation. Together these results suggest that a certain
level of PiT1 is important for proliferation. We have here investigated the role of PiT1 in regulation of cell
proliferation using two strictly density-inhibited cells lines, the murine MC3T3-E1 and NIH3T3 cells.
Results: We found that knock-down of PiT1 in MC3T3-E1 cells led to impaired proliferation supporting that at least
a certain level of PiT1 is important for wildtype level of proliferation. We, however, also observed that MC3T3-E1
and NIH3T3 cells themselves regulate their endogenous PiT1 mRNA levels with lower levels in general correlating
with decreased proliferation/increased cell density. Moreover, over-expression of human PiT1 led to increased
proliferation of both MC3T3-E1 and NIH3T3 cultures and resulted in higher cell densities in cultures of these two
strictly density-inhibited cell lines. In addition, when we transformed NIH3T3 cells by cultivation in fetal bovine
serum, cells over-expressing human PiT1 formed more colonies in soft agar than control cells.
Conclusions: We conclude that not only is a certain level of PiT1 necessary for normal cell division as suggested
by previously published studies, rather the cellular PiT1 level is involved in regulating cell proliferation and cell
density and an increased PiT1 expression can indeed make NIH3T3 cells more sensitive to transformation. We have
thus provided the first evidence for that expression of the type III Pi transporter, PiT1, above the endogenous level
can drive cell proliferation and overrule cell density constraints, and the results bridge previous observations
showing that a certain PiT1 level is important for regulating normal embryonic growth/development and for
tumorigenicity of HeLa cells.
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Background
The mammalian type III sodium-dependent inorganic
phosphate (NaPi) symporters, PiT1 (SLC20A1; formerly
GLVR1) and PiT2 (SLC20A2; formerly GLVR2 and
Ram1) [1-6] belong to the Pi transport (PiT) family
(SLC20; TC #2.A.20 [7]), which members are present in
all kingdoms of life [8]. The mammalian PiT proteins
were originally identified as receptors for gammaretro-
viruses [2,3,5]. Thus, e.g., human PiT1 (hPiT1) is receptor
for gibbon ape leukemia virus (GALV) [3] and feline leu-
kemia virus subgroup B (FeLV-B) [9] and human PiT2
(hPiT2) and murine PiT2 (mPiT2) are receptors for
a m p h o t r o p i cm u r i n el e u k e m i av i r u s( A - M L V )[ 1 , 5 ] .
There are, however, differences between the receptor
functions of PiT proteins from different species, e.g.,
unlike hPiT1, murine PiT1 (mPiT1) does not support
infection by GALV and FeLV-B [3,10-14]. * Correspondence: LP@mb.au.dk
1Department of Molecular Biology and Genetics, Aarhus University, 8000
Aarhus C, Denmark
Full list of author information is available at the end of the article
Byskov et al. Cell Division 2012, 7:7
http://www.celldiv.com/content/7/1/7
© 2012 Byskov et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Analysis of the Pi transport functions of the two human
PiT paralogs shows comparable abilities to transport Pi
[15]. Moreover, both paralogs are ubiquitously expressed
in mammalian cells and have been suggested to be
housekeeping Pi transporters supplying cells with their
general Pi needs [1,16-18] and thus to have overlapping
functions in cellular Pi import. This notion is supported
by results obtained by Beck and co-workers on an allelic
series of mutant mice in which PiT1 was expressed from
0 to 100% [19]. In agreement with results from Festing
and co-workers, they found that PiT1 knock-out mice
did not survive past E12.5 [19,20]. Beck and co-workers,
however, also found that E11.5 embryos showing PiT1
mRNA levels below 15% of that observed in wildtype
embryos, had up-regulated PiT2 expression. And the
authors could indeed not observe differences in the Pi
uptake abilities of mouse embryonic fibroblasts (MEFs)
derived from wildtype and PiT1-knock-out embryos [19].
These results suggest that PiT2 might be compensating
for the loss of PiT1 as a supplier, at least in part, of Pi to
the embryonic cells up to E11.5 to E12.5. However,
despite these suggested overlapping functions of PiT1
and PiT2 in cellular Pi import, Beck and co-workers also
showed that PiT1 possesses a cellular function, which
cannot be replaced by PiT2. Thus compared to wildtype
embryos, at E10.5 PiT1-knock-out embryos started to
show retarded growth and when investigated at E11.5
and/or E12.5, the PiT1 knock-out embryos also showed
reduced proliferation of liver cells [19]. Moreover,
although MEF cells derived from PiT1-knock-out
embryos and from embryos showing PiT1 mRNA levels
at 50% of wildtype levels had unimpaired Pi uptake abil-
ities, they did show severely impaired proliferation [19].
These observations suggest a function of PiT1 in prolif-
eration, which is not related to cellular Pi uptake. In line
with this, the same group has also shown that knock-
down of the expression of PiT1 in the two transformed
human cell lines, HeLa and HepG2, severely impairs
their proliferation [21]. In addition, HeLa cells with
knocked down PiT1 expression showed severely reduced
tumor growth after injection into nude mice compared
to control HeLa cells [21]. The impaired proliferation of
HeLa cells could not be rescued by over-expression of
PiT2 although the latter restored cellular Pi uptake to
nearly wildtype levels. However, expression of a PiT1
mutant unable to transport Pi did reestablish the prolif-
erative potential of the PiT1-knock-down cells [21].
Thus, the results from embryos and MEF and HeLa cells
suggest that the role of PiT1 in cell proliferation is not
related to PiT1 Pi uptake. Interestingly, studying MEF
cells with either knocked out PiT1 expression or PiT1
mRNA levels at 50% of wildtype levels, Beck and co-
workers found that the proliferative potentials of these
cells correlated with the levels of PiT1 expression [19].
Thus, the PiT1-knock-out MEFs proliferated very slowly
(2.1-fold decrease in doubling time compared to wild-
type), while the proliferative potential of the MEFs with a
50% reduction in PiT1 mRNA levels was between those
of the knock-out and wildtype MEFs [19]. The observa-
tions that lowering of the cellular PiT1 level led to
reduced proliferation of different cell types, and of mur-
ine as well as human cells, [19,21] suggest that mPiT1
and hPiT1 have the same function in cell proliferation
and that a certain level of PiT1 in general is necessary for
normal cell proliferation. In addition, these observations
also open for the possibility that the PiT1 level per se
m i g h tb ei n v o l v e di nc o n t r o l l i n gc e l lp r o l i f e r a t i o na s
hypothesized by Beck and co-workers [21]. In agreement
with this hypothesis, upon establishing and cultivating
murine MC3T3-E1 cells over-expressing hPiT1, we
noticed that the hPiT1 expressing cells grew to higher
densities than control cells albeit that the MC3T3-E1 cell
line exhibits strictly density-inhibited proliferation
(unpubl. observation).
We have here investigated the role of PiT1 in govern-
ing proliferation and cell density of two strictly density-
inhibited cell lines, the murine MC3T3-E1 [22] and
NIH3T3 [23] cells. In order to investigate whether an
increased PiT1 level could influence the proliferation of
these cells, we exploited, as elaborated above, that pre-
vious results suggest that mPiT1 and hPiT1 have the
same function in cell proliferation and used MC3T3-E1
and NIH3T3 cells stably expressing hPiT1 for our experi-
ments. This approach also allowed for verification of the
presence of functional transgenic hPiT1 protein at the
cell surface by exploiting the differences in retroviral
receptor functions of mPiT1 and hPiT1. Furthermore, it
allowed us to discriminate between exogenously and
endogenously expressed hPiT1 and mPiT1 mRNAs,
respectively, and thus to follow the mRNA levels of the
endogenous mPiT1 in murine cells stably expressing
hPiT1. Using a combination of PiT1 knock-down and
hPiT1 over-expression studies, we found that the level of
PiT1 in cells exhibiting density-inhibited growth, can
determine their proliferative potential and the density to
which these cells can grow. Specifically for both cell lines,
over-expression of hPiT1 led to increased proliferation
and cell density showing that a PiT1 level above the
endogenous level can drive cell proliferation and to some
degree overrule the cell density constraints of these
strictly density-inhibited cell lines. Moreover, upon inves-
tigating their ability to form colonies in soft agar, we also
found that over-expression of hPiT1 made NIH3T3 cells
more sensitive to transformation with fetal bovine serum
(FBS). We, furthermore, found that the endogenous PiT1
expression is regulated in a manner which indeed is in
agreement with a role of PiT1 in controlling cell prolif-
eration in density-inhibited cells.
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Knock-down of PiT1 impairs overall proliferation and cell
density in cultures of MC3T3-E1 cells
The pre-osteoblastic cell line, MC3T3-E1, was estab-
lished following a 3T3 cultivation scheme [22] and main-
tains strictly density-inhibited proliferation in our
laboratory when grown under conditions not inducing
differentiation (unpubl. observation). We investigated
how knock-down of the endogenous PiT1 (mPiT1) level
affected proliferation of this strictly density-inhibited cell
line. MC3T3-E1 cells with stable knock-down of PiT1
were made by transduction with a retroviral vector
encoding a miR-based shRNA against mPiT1, and the
cells are referred to as MC3T3-E1-PiT1shRNA. Com-
pared to control cells transduced with the empty transfer
vector (MC3T3-E1-LMP), MC3T3-E1-PiT1shRNA cells
showed about 20% knock-down of the mPiT1 mRNA
level (Figure 1A), and about 50% upregulation of the
mPiT2 mRNA level (Figure 1B). The PiT1 knock-down
did not influence the ability of the cells to import Pi
(Figure 1C). When MC3T3-E1-PiT1shRNA and MC3T3-
E1-LMP cells were seeded at 20,000 cells/cm
2 and
counted each day over 5 days, we observed that MC3T3-
E1-PiT1shRNA cultures in general showed decreased
proliferation and did not grow as dense as control
(MC3T3-E1-LMP) cultures (Figure 1D). Moreover, in
agreement with the importance of a certain PiT1 level for
cell proliferation, we experienced difficulties in maintain-
ing larger PiT1 knock-down levels in the stably trans-
duced cultures (unpubl. observations). Thus a certain
level of PiT1 was found to be important for proliferation
of MC3T3-E1 cells as has previously been shown for
MEFs and two human cancer cell lines [19,21]. More-
over, as observed for MEFs with down-regulated PiT1
expression [19], knock-down of PiT1 expression in
MC3T3-E1 cells led to upregulation of the PiT2 expres-
sion, but no change in Pi uptake.
The endogenous PiT1 mRNA level is decreased in dense
MC3T3-E1 cell cultures
The proliferation of the MC3T3-E1-PiT1shRNA cells
with knocked down PiT1 expression seemed to decline
from day 4 in culture while the control cultures had not
entirely stopped proliferating at days 4 and 5 (Figure 1D).
Figure 1 Knock-down of PiT1 in MC3T3-E1 cells decreases overall proliferation and cell density. A and B) qRT-PCR analyses. MC3T3-E1-
PiT1shRNA (PiT1shRNA) and MC3T3-E1-LMP (Control) cells were seeded at 20,000 cells/cm
2 and after 2 days in culture, the mPiT1 (A) and mPiT2
(B) mRNA levels were analyzed by qRT-PCR. Each column represents cell lysates from three wells and triplicate qRT-PCR analyses of each cell
lysate. The mPiT1 and mPiT2 mRNA levels are standardized to B2M mRNA levels. Data are means ± standard deviation (SD).*indicates statistically
significantly different from control cells, p < 0.05. C) Pi-transport assay. MC3T3-E1-PiT1shRNA (PiT1shRNA) and MC3T3-E1-LMP (Control) cells were
seeded at 50,000 cells/cm
2 in 4-well plates. Two days after,
32Pi import in Pi-free medium (with 5 μM
32Pi only) was analyzed over 5 minutes. The
results are shown as mean
32Pi import per mg protein per hour of 4 wells ± SD. D) Cell counts. MC3T3-E1-PiT1shRNA (PiT1shRNA) and MC3T3-
E1- LMP (Control) cells were seeded at 20,000 cells/cm
2 in 4-well plates and counted at the indicated days. The results are shown as mean cell
number per cm
2 of 4 wells ± SD.* indicates statistically significantly different from control cells at the same day, p < 0.05.
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terns were observed between MEF cells with decreased
PiT1 expression and control cells [19]. This is intriguing
since in either experiment had the cells with lowered
PiT1 expressions, at the time they stopped proliferating,
not reached the density of the control cultures (Figure
1D and ref. [19]). We have previously observed that the
endogenous PiT1 mRNA level decreases in MC3T3-E1
cells over time in culture, i.e., as the cultures grow denser
(unpubl. observations). To investigate whether the PiT1
expression was down-regulated as a consequence of den-
sity or time in culture, MC3T3-E1 cells were seeded at
5,000 cells/cm
2 (sparsely) or 50,000 cells/cm
2 (densely)
and two days later, the PiT1 mRNA levels were analyzed
(Figure 2). The cells seeded sparsely had more than 4
times higher PiT1 mRNA levels compared to densely
seeded cells; thus the mPiT1 mRNA levels in the
MC3T3-E1 cell line correlate with cell density rather
than time in culture, with less dense cultures showing
higher mPiT1 mRNA levels than denser cultures.
Together with the observed ceased proliferation of the
MC3T3-E1 (Figure 1D) and MEF [19] cells with lowered
PiT1 levels, despite the capacity of the control cultures to
grow denser, these results may suggest that the PiT1
level also influences how dense the cells can grow.
Characterization of MC3T3-E1 cells over-expressing hPiT1
or hPiT2
The observation that knock-down of the PiT1 mRNA level
in human [21] and murine (Figure 1D and ref. [19]) cells
led to impaired proliferation and cell density strongly
suggest that PiT1 has the same function in cell prolifera-
tion in mouse and man. In order to further address the
role of the PiT1 level in cell proliferation and cell density,
we therefore employed MC3T3-E1 cells stably expressing
hPiT1. The use of hPiT1 allowed us both to investigate
whether the transgenic hPiT1 protein was present in the
cell membrane and to discriminate between endogenous
and exogenous PiT1 mRNA levels in the cells.
We established populations of MC3T3-E1 cells stably
expressing hPiT1 (MC3T3-E1-LPiT1SN), hPiT2 (MC3T3-
E1-LPiT2SN), or empty transfer vector (MC3T3-E1-LXSN)
by retroviral transduction. The transgenic hPiT1 and hPiT2
were found to be expressed in MC3T3-E1-LPiT1SN and
-LPiT2SN cells, respectively, at the mRNA level by quanti-
tative RT-PCR (qRT-PCR) analysis (Figure 3A). We
exploited the retroviral receptor functions of hPiT1 and
hPiT2 to analyze for their presence on the cell surface
using binding assays employing the receptor binding
domains (RBDs) of the two viruses FeLV-B and A-MLV,
respectively. FeLV-B can use hPiT1 but not mPiT1 as
receptor and, in agreement with this, MC3T3-E1-LXSN
cells did not bind FeLV-B RBD, while MC3T3-E1-LPiT1SN
cells bound FeLV-B RBD showing that hPiT1 was present
at the surface of these cells (Figure 3B). MC3T3-E1-
LPiT2SN cells did not show increased FeLV-B binding
compared to MC3T3-E1-LXSN cells, in agreement with
that hPiT2 does not bind FeLV-B (Figure 3B). As well
mPiT2 as hPiT2 are receptors for A-MLV, accordingly,
MC3T3-E1-LXSN cells showed A-MLV RBD binding,
however, MC3T3-E1-LPiT2SN cells exhibited increased A-
MLV RBD binding showing that hPiT2 was present at the
surface of these cells (Figure 3B). MC3T3-E1-LPiT1SN
cells did not show increased A-MLV binding compared to
MC3T3-E1-LXSN cells, showing that expression of hPiT1
did not lead to increased expression of endogenous mPiT2
(Figure 3B). The surface expression of functional hPiT1
and hPiT2 can be analyzed by investigating the transduc-
tion of the cells by retroviral vectors carrying surface pro-
teins of viruses, which can use the proteins as receptors.
We here used GALV and A-MLV pseudotyped GBN
transfer vectors, where GBN encodes b-galactosidase.
GALV can, as FeLV-B, use hPiT1 but not mPiT1 as a
receptor (Table 1). The exogenously expressed hPiT1 and
hPiT2 proteins were functionally expressed at the cell
membrane of MC3T3-E1-LPiT1SN and MC3T3-E1-
LPiT2SN, respectively, in that MC3T3-E1-LPiT1SN cells
were susceptible to transduction with GALV pseudotyped
GBN vectors and MC3T3-E1-LPiT2SN cells showed
increased transduction with A-MLV pseudotyped GBN
vectors compared to MC3T3-E1-LPiT1SN and control
(MC3T3-E1-LXSN) cells (Table 1).
The endogenous mPiT1 and mPiT2 mRNA levels were
also followed over time in culture in MC3T3-E1-LXSN,
-LPiT1SN, and -LPiT2SN cells. In the experiment shown
Figure 2 Expression of endogenous PiT1 in MC3T3-E1 cells.
MC3T3-E1 cells were seeded at 5,000 and 50,000 cells/cm
2 in 4-well
plates and 2 days after seeding, the mRNA levels of mPiT1 were
analyzed by qRT-PCR. Each column represents cell lysates from
three wells and triplicate qRT-PCR analyses of each cell lysate. The
mPiT1 mRNA levels are standardized to B2M mRNA levels. Data are
means ± SD.* indicates statistically significantly different from
MC3T3-E1 cells seeded at 5,000 cells/cm
2, p < 0.05.
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Page 4 of 16Figure 3 Characterization of MC3T3-E1 cells over-expressing hPiT1 or hPiT2. A) qRT-PCR analysis of exogenously expressed hPiT1 and
hPiT2 mRNA levels in MC3T3-E1-LXSN (LXSN), MC3T3-E1-LPiT1SN (LPiT1SN), and MC3T3-E1-LPiT2SN (LPiT2SN) cells, respectively. Each column
represents cell lysates from three wells and triplicate qRT-PCR analyses of each cell lysate. The hPiT1 and hPiT2 mRNA levels are standardized to
the endogenous B2M mRNA levels. Data are means ± SD. “No CT” indicates that no signal was obtained for the transgene examined. * indicates
statistically significantly different from MC3T3-E1-LXSN (control) cells, p <0.05. B) RBD-binding assay. MC3T3-E1-LXSN (LXSN), MC3T3-E1-LPiT1SN
(LPiT1SN), and MC3T3-E1-LPiT2SN (LPiT2SN) cells were incubated with His-tagged FeLV-B RBD or His-tagged A-MLV RBD containing supernatant
(dashed line) or in standard growth medium containing no RBD (solid line) followed by a mouse-anti-His antibody and finally a PE-conjugated
goat anti-mouse Ig antibody. The cells were analyzed by flow cytometry. The x-axis shows PE intensity measured in the FL2-H channel. C and D)
Expression of endogenous mPiT1 and mPiT2. MC3T3-E1-LXSN (LXSN), MC3T3-E1-LPiT1SN (LPiT1SN), and MC3T3-E1-LPiT2SN (LPiT2SN) cells were
seeded at 500 cells/cm
2 in 6-well plates and the endogenous mPiT1 mRNA levels were analyzed by qRT-PCR at the indicated days in culture.
Each column represents six wells, but since the wells were harvested two and two in the same cell lysis buffers, the columns represent three
lysates, and triplicate qRT-PCR analyses of each cell lysate. The mPiT1 and mPiT2 mRNA levels are standardized to B2M mRNA levels. Data are
means ± SD. E) Pi-transport assay. MC3T3-E1-LXSN (LXSN), MC3T3-E1-LPiT1SN (LPiT1SN), and MC3T3-E1-LPiT2SN (LPiT2SN) cells were seeded at
20,000 cells/cm
2 in 4-well plates. The next day,
32Pi import in medium containing a total [Pi] of 100 μM was analyzed over 5 minutes. The results
are shown as mean
32Pi import per mg protein per hour of 4 wells ± SD. * indicates statistically significantly different from MC3T3-E1-LXSN
(control) cells, p < 0.05.
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cm
2, thus the cells grew in colonies. In agreement with
the observed regulation of endogenous mPiT1 in wild-
type MC3T3-E1 cells, the mPiT1 mRNA levels decreased
when the cells started to touch each others within the
colonies, i.e., approximately around 3-5 days in culture in
the experiment shown (Figure 3C). No significant differ-
ence in mPiT1 mRNA levels was observed between
MC3T3-E1-LXSN, -LPiT1SN or -LPiT2SN cells (Figure
3C) indicating that the expression of the endogenous
mPiT1 was not per se influenced by the exogenously
expressed hPiT1 or hPiT2. The endogenous mPiT2
mRNA levels decreased from day 1 to 3 in culture and
remained thereafter at the same level (Figure 3D). At day
5 in culture, MC3T3-E1-LPiT1SN cells showed lower
mPiT2 mRNA levels than the other cultures, but other-
wise, no significant difference in mPiT2 mRNA levels
was observed between MC3T3-E1-LXSN, -LPiT1SN or
-LPiT2SN cells (Figure 3D) indicating that the expression
of the endogenous mPiT2 was not per se influenced by
the exogenously expressed hPiT1 or hPiT2.
Over-expression of hPiT1 in MC3T3-E1 cells increases cell
proliferation and cell density
To further address the importance of the PiT1 level in
cell proliferation and cell density, we employed the
hPiT1 expressing MC3T3-E1-LPiT1SN cells to investi-
gate whether increased PiT1 expression levels could
influence the proliferation of the MC3T3-E1 cell line. In
o r d e rt ob ea b l et of o l l o wt h ep o s s i b l ee f f e c t so fh P i T 1
over-expression on cell proliferation and cell density,
and at the same time allowing a uniform cell density in
the cultures, we seeded MC3T3-E1-LPiT1SN cells and,
as control, MC3T3-E1-LXSN cells at densities of 20,000
cells/cm
2 (Figure 4A). We found that cultures of the
hPiT1 expressing MC3T3-E1-LPiT1SN cells showed
increased proliferation until day 3 in culture and, in
agreement with our previous observations, achieved a
higher cell density after 4 days in culture than cultures
of control MC3T3-E1-LXSN cells (11.8 × 10
4 cells/cm
2
compared to 10.6 x 10
4 cells/cm
2, respectively, in the
experiment shown in Figure 4A). This observation is
not trivial since MC3T3-E1 cells show strictly density-
inhibited proliferation. We also analyzed the influence
of over-expression of hPiT1 on the distribution of cells
in the G0/G1, S, and G2/M phases of the cell cycle at
day 1 in culture in independent set-ups (Figures 4B and
4C). In agreement with the increased proliferative
potential of the hPiT1 expressing MC3T3-E1-LPiT1SN
cells, cultures of these had a statistically significantly
higher number of cells in S + G2/M compared to con-
trol cultures (53.9 ± 0.7 compared to 49.1 ± 0.5, respec-
tively). Thus, if the PiT1 level is kept at a higher level
than in control cells by exogenous expression of hPiT1
in the strictly density-inhibited MC3T3-E1 cells, the
cells show initially higher proliferation and can grow to
a higher density than control cells. Unlike MC3T3-E1-
LPiT1SN cells, cultures of MC3T3-E1 cells expressing
hPiT2, MC3T3-E1-LPiT2SN, did not show increased
number of cells in S + G2/M phases compared to con-
trol cultures (Figures 4B and 4C). To summarize, a cer-
tain PiT1 level is not only important for proliferation of
MC3T3-E1 cells, an increase in the PiT1 level can impel
proliferation and to some degree overrule the con-
straints on cell density.
Effect of regulation of PiT1 and PiT2 expressions on the
ability of MC3T3-E1 cells to import Pi
The impaired proliferation of MC3T3-E1 (Figure 1D)
and the previously reported impaired proliferation of
MEF cells [19], as consequences of knock-down of PiT1
expression, were both associated with upregulated PiT2
expression and neither could be related to decreased
cellular Pi import. Moreover, the previously reported
down-regulatory effect of knock-down of PiT1 on pro-
liferation of HeLa cells was shown to be independent
on the ability of PiT1 to transport Pi [21]. We, more-
over, find that when seeded at a density of 50,000 cells/
cm
2, or 20,000 cells/cm
2 as in the experiment shown in
Figure 4, analyses of the Pi uptake as in the experiment
shown in Figure 1C show that the ability of MC3T3-E1-
LPiT1SN cells to import Pi is indistinguishable from
that of MC3T3-E1-LXSN cells, while that of MC3T3-
E1-LPiT2SN cells is several fold higher (unpubl. results).
The Km’s of hPiT1 and hPiT2 are in the range of 100
to 300 μMP i [15], and the Pi uptake was also analyzed
in the presence of 100 μM and 300 μMP i. However, no
increase in Pi uptake by the MC3T3-E1-LPiT1SN cells
compared to control MC3T3-E1-LXSN cells was
Table 1 Transduction study analyzing the presence of
functional hPiT1, hPiT2, and mPiT2 on the cell surface of
MC3T3-E1-LXSN, -LPiT1SN, -LPiT2SN, NIH3T3-LXSN, and -
LPiT1SN cells
Cells
a) Pseudotype of vectors encoding LacZ
A-MLV
b) GALV
MC3T3-E1-LXSN 4.7 × 10
4c ) 0
d)
MC3T3-E1-LPiT1SN 4.5 × 10
4 4.3 × 10
3
MC3T3-E1-LPiT2SN 6.5 × 10
4 0
NIH3T3-LXSN 6.4 × 10
5 0
NIH3T3-LPiT1SN 5.4 × 10
5 3.6 × 10
4
a) MC3T3-E1 cells transduced with empty vector (LXSN), LPiT1SN, or LPiT2SN
retroviral vectors were challenged with retroviral vectors pseudotyped with
A-MLV or GALV surface proteins and carrying a b-galactosidase encoding
transfer vector.
b) The titers on D17 cells of the vector stocks used were 1.7 × 10
5 CFU/mL
(A-MLV pseudotype) and 1.9 × 10
5 CFU/mL (GALV pseudotype).
c) Numbers indicate blue CFU per mL vector containing supernatant.
d) No blue cells were detected in the wells.
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μMP i (not shown); MC3T3-E1-LPiT2SN cells showed
4-fold (100 μMP i) (Figure 3E) and 3.3-fold (300 μMP i)
(not shown) increased Pi uptake compared to control
MC3T3-E1-LXSN cells. The lack of increased Pi import
in the PiT1 over-expressing MC3T3-E1 cells are in sup-
port of that the effects of the PiT1 level on the prolif-
eration and density of MC3T3-E1 cells could be
independent of its Pi-transport function. Further sup-
porting that the cellular Pi import per se is not the
cause of the effect of the increased PiT1 level on the
proliferative potential of MC3T3-E1 cells is that
MC3T3-E1-LPiT2SN cells, which exhibited increased Pi
uptake ability, showed the opposite pattern of distribu-
tion of cells in G0/G1 and S + G2/M than MC3T3-E1-
LPiT1SN cells (Figure 4C).
Figure 4 Over-expression of hPiT1 increases proliferation and cell density of MC3T3-E1 cultures. A) Cell counts. MC3T3-E1-LPiT1SN
(LPiT1SN) (crosses) and control cells (MC3T3-E1-LXSN (LXSN)) (squares) cells were seeded at 20,000 cells/cm
2 in 4-well plates and counted at the
indicated days. The results are shown as mean cell number per cm
2 of 4 wells ± SD. *indicates statistically significantly different from MC3T3-E1-
LXSN cells at the same day, p <0.05. B and C) Cell cycle analysis. MC3T3-E1-LPiT1SN (LPiT1SN), MC3T3-E1-LXSN (LXSN), and MC3T3-E1-LPiT2SN
(LPiT2SN) were seeded at 20,000 cells/cm
2 in T25-flasks, stained with propidium iodide 24 hours later, and analyzed by flow cytometry. B)
Representative flow cytometry histograms of MC3T3-E1-LXSN (LXSN) (top), MC3T3-E1-LPiT1SN (LPiT1SN) (middle), and MC3T3-E1-LPiT2SN
(LPiT2SN) (bottom) cells; the thick black lines represent the Watson-Pragmatic model. C) The percentages of cells in the respective phases of the
cell cycle obtained using the Watson Pragmatic model. Each column represents the mean of triplicate set ups ± SD. *indicates statistically
significantly different from MC3T3-E1-LXSN (control) cells in the same phases of the cell cycle, p < 0.05.
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To address whether the effects of hPiT1 over-expression
on regulation of cell proliferation and density of MC3T3-
E1 cells are cell-type specific and/or are a result of
MC3T3-E1 being a pre-osteoblastic cell line, for which
PiT1 is important in differentiation/mineralization
(unpubl. results) [24,25], we wished to investigate the
effects of hPiT1 over-expression on the murine fibroblas-
tic cell line, NIH3T3. The NIH3T3 cell line, like the
MC3T3-E1 cell line, was established following a 3T3 cul-
tivation scheme [23]; it maintains strictly density-inhib-
ited proliferation in our laboratory when cultivated in
newborn calf serum (unpubl. observation). Populations of
NIH3T3 cells that stably express hPiT1 (NIH3T3-
LPiT1SN) or empty vector (NIH3T3-LXSN) were estab-
lished by retroviral transduction. NIH3T3-LPiT1SN cells
were shown to express hPiT1 at the mRNA level by qRT-
PCR analysis (Figure 5A). The presence of the hPiT1 pro-
teins on the cell surface was analyzed using the binding
assay employing FeLV-B RBD, which as mentioned
above, can bind hPiT1 but not mPiT1. As expected,
NIH3T3-LXSN cells did not show binding of FeLV-B
RBD, however, NIH3T3-LPiT1SN cells bound FeLV-B
RBD showing that the hPiT1 protein was present at the
surface of these cells (Figure 5B). Furthermore, we found
that NIH3T3-LPiT1SN cells were susceptible to trans-
duction with GALV pseudotyped GBN vector, and since
GALV can only use hPiT1 and not mPiT1 as a receptor,
this shows that the exogenously expressed hPiT1 protein
was functionally expressed at the cell surface of the
NIH3T3-LPiT1SN cells (Table 1). The endogenous
mPiT2 is as mentioned above a receptor for A-MLV and
in agreement with this, NIH3T3-LXSN cells showed A-
MLV RBD binding (Figure 5B) and were transduced with
A-MLV pseudotyped vectors (Table 1). NIH3T3-
LPiT1SN cells did, however, not show increased A-MLV-
specific binding (Figure 5B) or transduction (Table 1)
compared to NIH3T3-LXSN cells, showing that expres-
sion of hPiT1 did not lead to increased expression of
endogenous mPiT2 at the cell surface.
Over-expression of hPiT1 in NIH3T3 cells increases cell
proliferation and cell density
The effects of expressing hPiT1 on proliferation and den-
sity of NIH3T3 cells were investigated by seeding
NIH3T3-LPiT1SN and, as control, NIH3T3-LXSN cells
at densities of 20,000 cells/cm
2 and following the cell
numbers each day over 5 days in culture (Figure 6A).
Cultures of the hPiT1 expressing NIH3T3-LPiT1SN cells
showed increased proliferation the first two days in cul-
ture and were able to grow denser compared to cultures
of control NIH3T3-LXSN cells (e.g., 11.9 × 10
4 cells/cm
2
compared to 8.26 × 10
4 cells/cm
2, respectively, after 5
days in culture in the experiment shown in Figure 6A).
We also analyzed the influence of over-expression of
hPiT1 on the distribution of cells in the G0/G1, S, and
G2/M phases of the cell cycle 8, 12, and 24 hours after
seeding in an independent set-up (Figures 6B and 6C). At
8 hours after seeding, there was no difference in the dis-
tribution of cells in the G0/G1 and S + G2/M phases of
the cell cycle between hPiT1 over-expressing cells and
control cells. However, in agreement with their increased
proliferative potential, NIH3T3-LPiT1SN cultures
showed a statistically significantly higher number of cells
in S + G2/M compared to control cultures at 12 (63.3 ±
0.8 compared to 53.3 ± 0.8, respectively) and 24 hours
(35.9 ± 1.5 compared to 28.8 ± 0.8, respectively) after
seeding. Thus in NIH3T3 cells, an increased PiT1 level
can also drive proliferation and overrule the constraints
on cell density.
In the experiment in Figure 6A, we also followed the
endogenous mPiT1 and mPiT2 mRNA levels during the
entire cultivation period (Figures 7A and 7B). Over-
expression of hPiT1 led to a slight albeit not statistically
significantly increased level of endogenous mPiT2
mRNA at day 1 in culture (compare NIH3T3-LXSN and
NIH3T3-LPiT1SN at day 1 in Figure 7B), which how-
ever, in agreement with its non-significant size, was not
reflected in the level of mPiT2 protein in the membrane
(A-MLV binding assay in Figure 5B and A-MLV trans-
duction assay in Table 1); no differences in the mRNA
levels of endogenous mPiT2 were observed between
NIH3T3-LXSN and NIH3T3-LPiT1SN cells at the
remaining time points (Figure 7B). Over-expression of
hPiT1 did not affect the endogenous mPiT1 mRNA
levels, since NIH3T3-LPiT1SN and control NIH3T3-
LXSN cells exhibited similar mPiT1 mRNA levels at day
1 in culture (Figure 7A). The proliferation of the control
NIH3T3-LXSN cells varied over the entire cultivation
period, but was lowest between days 2 and 3; interest-
ingly, the endogenous mPiT1 level was lowest at day 3.
The NIH3T3-LPiT1SN cells had stopped proliferating at
day 2 in culture at a high cell density, and the mRNA
level of endogenous mPiT1 was down-regulated at day 2
in these cells and stayed down to the end of the cultiva-
tion period (Figure 7A).
Effect of over-expression of hPiT1 on the ability of
NIH3T3 cells to import Pi
The effect of over-expressing hPiT1 on the ability of
NIH3T3 cells to import Pi was also investigated. Unlike
MC3T3-E1 cells, which did not support increased Pi
import when hPiT1 was over-expressed, the hPiT1
expressing NIH3T3-LPiT1SN cells were found to sup-
port increased (approximately 20-fold) Pi import com-
pared to control NIH3T3-LXSN cells (Figure 7C).
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Page 8 of 16Figure 5 Characterization of NIH3T3 cells over-expressing hPiT1. A) qRT-PCR analysis of exogenously expressed hPiT1 in NIH3T3-LPiT1SN
(LPiT1SN) and NIH3T3-LXSN (LXSN) cells. Each column represents cell lysates from three wells and triplicate qRT-PCR analyses of each cell lysate.
The hPiT1 mRNA levels are standardized to the endogenous B2M mRNA levels. Data are means ± SD.* indicates statistically significantly different
from NIH3T3-LXSN (control) cells. B) RBD-binding assay. Analyses of binding of His-tagged FeLV-B RBD and A-MLV RBD to NIH3T3-LXSN (LXSN)
and NIH3T3-LPiT1SN (LPiT1SN) cells were performed as described in the legend to Figure 3. Incubations with His-tagged FeLV-B RBD containing
supernatant (dashed line) or standard growth medium (solid line) are shown. The x-axis shows PE intensity measured in the FL2-H channel.
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NIH3T3 cells to form colonies in soft agar
Previous studies showed that down-regulation of the PiT1
level in HeLa cells impaired their ability to form tumors in
nude mice [21]. In order to investigate whether it was pos-
sible to bridge these data with the here found role of
increased PiT1 level on proliferation of density-inhibited
cells, we exploited that part of the cells in density-inhibited
NIH3T3 cultures can be transformed by cultivation in
FBS. Thus, NIH3T3-LPiT1SN and control NIH3T3-LXSN
cells were cultivated in FBS for 2 days and their abilities to
form colonies in soft agar were investigated; as control,
cultures cultivated in normal growth medium, i.e., con-
taining NCS, were also included in the soft agar assay
shown in Table 2. For both NIH3T3-LPiT1SN and control
NIH3T3-LXSN, only the cultures cultivated in FBS for
2 days formed substantial numbers of colonies in soft
agar, however, a statistically significant increase in the
number of colonies was found in soft agar cultures of
NIH3T3-LPiT1SN cells compared to NIH3T3-LXSN cells
(97.5 ± 9.1 and 69.0 ± 8.3, respectively). Thus over-expres-
sion of hPiT1 made the NIH3T3 cells more sensitive to
transformation with FBS.
Discussion
In the present work, we show that the type III NaPi trans-
porter, PiT1, can regulate proliferation and cell density of
two different non-transformed cell lines, MC3T3-E1 and
NIH3T3, which both exhibit strictly density-inhibited cell
proliferation, and that over-expression of PiT1 indeed
made NIH3T3 cells more sensitive to transformation
with FBS. Working with MC3T3-E1 cells, we found in
agreement with the in vitro work of Beck and co-workers
in MEF, HeLa, and HepG2 cells [19,21] and the reported
effect of PiT1 knock-out on proliferation of liver cells in
the developing embryo [19], that lowering of the PiT1
Figure 6 Over-expression of hPiT1 increases proliferation and cell density of NIH3T3 cultures. A) Cell counts. Control (NIH3T3-LXSN
(LXSN)) (squares) and NIH3T3-LPiT1SN (LPiT1SN) (crosses) cells were seeded at 20,000 cells/cm
2 in 4-well plates and counted at the indicated
days. The results are shown as mean cell number per cm
2 of 4 wells ± SD. *indicates statistically significantly different from NIH3T3-LXSN cells at
the same day, p < 0.05. B and C) Cell cycle analysis. NIH3T3-LPiT1SN (LPiT1SN) and NIH3T3-LXSN (LXSN) were seeded at 20,000 cells/cm
2 in T25-
flasks, and cultures were stained with propidium iodide 8, 12, and 24 hours later, and analyzed by flow cytometry. B) Representative flow
cytometry histograms of NIH3T3-LXSN (LXSN) (left) and NIH3T3-LPiT1SN (LPiT1SN) (right) cells at 24 hours after seeding; the thick black lines
represent the Watson-Pragmatic model. C) The percentages of cells in the respective phases of the cell cycle 8, 12, and 24 hours after seeding as
indicated obtained using the Watson Pragmatic model. Each column represents the mean of triplicate set ups ± SD. *indicates statistically
significantly different from NIH3T3-LXSN (control) cells in the same phases of the cell cycle, p < 0.05.
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Page 10 of 16level led to impaired cell proliferation; interestingly, so
far we have not identified a PiT1-knock-down level,
which the NIH3T3 cells could survive (unpubl. observa-
tions). Thus, a certain PiT1 level is necessary for main-
taining the wildtype proliferative potentials of a number
of different cell lines/cell types. We, however, also found
that over-expression of PiT1 increased the proliferation
and culture densities of MC3T3-E1 and NIH3T3 cells
and made NIH3T3 cells more sensitive to transformation
with FBS. This is the first time that it is shown that an
increase in the PiT1 expression above the endogenous
levels of cells is sufficient to increase cell proliferation
and that it indeed also can increase the density to which
strictly density-inhibited cell lines can grow as well as
increase anchorage independent growth/transformation.
Thus, not only is a certain level of PiT1 necessary for
normal cell proliferation (Figure 1 and refs. [19,21]), an
increased PiT1 level above the endogenous level of the
cell can impel proliferation and to some degree overrule
the constraints on cell density. Hence, the results suggest
that PiT1 is not only necessary for normal cell prolifera-
tion, but can regulate the proliferative potential of cells,
cell density, and anchorage-independent growth.
Investigations of the endogenous PiT1 mRNA level in
control MC3T3-E1 and NIH3T3 cells showed that it
seemed to follow the proliferative potential of the cells, i.
e., the lowest PiT1 mRNA levels were found in cultures
showing a low degree of proliferation, in agreement with a
role of the endogenous PiT1 level in proliferation. Our
observations also suggest a role of the endogenous PiT1
level in regulating cell density. Thus we found that the
endogenous PiT1 mRNA level was down-regulated in
dense cultures. Moreover, while increasing the PiT1 levels
in NIH3T3 and MC3T3-E1 cells by over-expressing hPiT1
did not lead to an obvious abrogation of the density-inhib-
ited cell proliferation per se, the cultures did grow to
higher cell densities than control cell cultures before they
stopped proliferating. Furthermore, while the NIH3T3
cells over-expressing hPiT1 showed similar endogenous
Figure 7 Effect of over-expression of hPiT1 in NIH3T3 cells on
the endogenous mPiT1 and mPiT2 mRNA levels and Pi uptake.
A and B) qRT-PCR analyses of endogenously expressed mPiT1 and
mPiT2. NIH3T3-LXSN (LXSN) and NIH3T3-LPiT1SN (LPiT1SN) cells
were seeded at 20,000 cells/cm
2 in 4-well plates and the
endogenous mPiT1 (A) and mPiT2 (B) mRNA levels were analyzed
by qRT-PCR at indicated days in culture. Each column represents cell
lysates from three wells and triplicate qRT-PCR analyses of each cell
lysate. The mPiT1 and mPiT2 mRNA levels are standardized to B2M
mRNA levels. Data are means ± SD. * indicates statistically
significantly different from NIH3T3-LXSN (control) cells at the same
day, p < 0.05. E) Pi-transport assay. NIH3T3-LXSN (LXSN) and NIH3T3-
LPiT1SN (LPiT1SN) cells were seeded at 20,000 cells/cm
2 in 4-well
plates. The next day,
32Pi import in medium containing a total [Pi]
of 100 μM was analyzed over 5 minutes. The results are shown as
mean
32Pi import per mg protein per hour of 4 wells ± SD. *
indicates statistically significantly different from NIH3T3-LXSN
(control) cells, p < 0.05.
Table 2 Colony formation by NIH3T3-LXSN and NIH3T3-




NIH3T3-LXSN 0.5 ± 0.5
c) 69.0 ± 8.3
NIH3T3-LPiT1SN 2.5 ± 1.8 97.5 ± 9.8
d)
a) The cells were cultured in normal growth medium prior to as well as during
cultivation in soft agar (DMEM supplemented with 10% NCS and 1% PS).
b) The cells were cultured in transformation medium 2 days prior to as well as
during cultivation in soft agar (DMEM supplemented with 10% FBS and 1% PS).
c) Numbers indicate mean numbers of colonies per well of 4 wells ± SD.
d) Statistically significantly different from colonies derived from NIH3T3-LXSN
(control) cells grown in FBS, p < 0.05.
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at day 2 in culture, these cells had reached their maximal
density and had down-regulated the endogenous PiT1
mRNA levels, which stayed down. It is possible that the
down-regulation of endogenous PiT1 could have occurred
at a lesser cell density than the maximal density of the
hPiT1 over-expressing cultures, since over-expression of
hPiT1 led to higher cell densities, than observed in control
cultures, and we only had one analysis-point per day.
Nevertheless, the observed down-regulation of the endo-
genous PiT1 expression in response to cell density is inter-
esting in that the studies of MC3T3-E1 (Figure 1) and
MEF [19] cells showed that down-regulation of their PiT1
mRNA levels was sufficient to down-regulate the prolifera-
tion of these cells and that they ceased to proliferate
although they had not reached the density of the control
cells. It is in this respect also interesting, that Beck and co-
workers reported on a less dense packaging of cells in the
liver of PiT1 knock-out embryos [19]. Together these data
make us hypothesize that the cells themselves utilize their
PiT1 levels to control their proliferation in response to cell
density, i.e., when the cells attain a certain density, they
down-regulate the endogenous PiT1 level, which again
leads to down-regulation of the proliferation.
It is currently not known how the increased and
decreased PiT1 levels lead to increased and decreased,
respectively, cell proliferation. Beck and co-workers
found that impairment of proliferation of HeLa cells by
knock-down of endogenous PiT1 could be rescued by a
PiT1 mutant (S128A mutation), which is unable to trans-
port Pi, but not by over-expression of PiT2 albeit the lat-
ter nearly restored the Pi uptake ability of the cells to
wildtype level [21]. Furthermore, Beck and co-workers
a l s of o u n dt h a tt h ei m p a i r e dproliferation of MEF cells
with down-regulated PiT1 expression was not due to
impaired cellular Pi uptake [19]. In the present work, did
over-expression of hPiT1 not lead to increased Pi uptake
in MC3T3-E1 cells. However, over-expression of hPiT2
in these cells did lead to increased Pi uptake ability, but
not to an increased proportion of cells in the S + G2/M
phases of the cell cycle as over-expression of hPiT1 did.
Thus, we have no evidence supporting that the here
shown function of PiT1 in cell proliferation in MC3T3-
E1 cells is related to Pi translocation by PiT1. However,
since hPiT1 over-expression did increase the Pi-uptake
ability of NIH3T3 cells, we can presently not rule out
that increased Pi import play a role in NIH3T3 cells.
Given the ubiquitous expression of PiT1 in mammalian
cells [17], we do however hypothesize that the mechan-
ism by which the PiT1 level exerts its function in the reg-
ulation of cell proliferation/cell density is the same in the
different cell types.
In PiT1-deficient MEF cells, Beck and co-workers
investigated the activation of S6K1, S6, Akt1, and 4EBP1,
which are proteins involved in coupling signals from
growth factors and nutrients to coordinate cell growth
and cell division, but found no defects in their regulation
[19]. It should, however, be stressed that numerous stu-
dies show that PiT1 is a genuine cellular Pi transporter,
i . e . ,t h a ti ti sa b l et oi m p o r tP i into cells, hereunder stu-
dies in Xenopus laevis oocytes [1,4,15,18,26], as we also
find when we over-express hPiT1 in NIH3T3 cells. Thus,
although the role of PiT1 in regulating cell proliferation
may not be directly linked to its Pi transport function, we
nevertheless hypothesize that the role of the PiT1 level in
regulating cell proliferation, relates to PiT1’s suggested
role in cellular Pi homeostasis albeit in a yet unknown
manner. It is in this respect, however, interesting that the
yeast Pi transporter, Pho84, can function as a nutrient
sensor, a transceptor [27]. Results obtained by Popova
and co-workers suggest that binding of phosphate/phos-
phate-containing compounds to Pho84 can elicit a signal
transduction. The Pho84-mediated signal transduction
did require a specific conformational change as in a Pi-
transport-process, but not a complete transport cycle,
thus Pi translocation was not involved in the signal trans-
duction [27]. Albeit, it is not known whether PiT1 has
transceptor function, it is important to notice that if
there is analogy to the transceptor function of Pho84, a
PiT1 Pi transport knock-out mutant, as, e.g., the PiT1
S128A mutation shown to be able to rescue the impair-
ment of proliferation of HeLa cells caused by knock-
down of endogenous PiT1 [21], could be captured in a
constitutive signaling conformation.
Another question arises from the present and published
results on the role of PiT1 as a regulator of cell prolifera-
tion/cell density, namely, whether the abilities of PiT1 to
transport Pi and function as a regulator of cell prolifera-
tion/cell density are functions that are performed by the
same PiT1 molecule? It is in this respect interesting, that
PiT1 has been published to be able to bind another ubi-
quitously expressed protein, the multimembrane-spanning
protein, progressive ankylosis protein (ANK), which
exports pyrophosphate out of the cell [28]. How this bind-
ing affects the function of PiT1, is, however, not yet clear.
Conclusions
We conclude that not only is a certain level of PiT1
necessary for normal cell division as suggested by pre-
vious published results, rather the cellular PiT1 level is
involved in regulating cell proliferation and cell density,
and expression of PiT1 above the endogenous level can
drive cell proliferation, overrule cell density constraints,
and indeed make NIH3T3 cells more sensitive to trans-
formation. We have thus provided the first evidence for
ar o l eo ft h et y p eI I IP i transporter, PiT1, as a protein,
which can increase normal cell proliferation and cell
density.
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Expression plasmids and transfer vectors
The expression plasmids pOJ74 and pOJ75 (Wyeth-Ayerst
Research, Pearl River N.Y., USA) encoding hPiT2 and
hPiT1, respectively, have been described [11]. The pLXSN
[29] derivatives, pLPiT1SN and pLPiT2SN carrying the
open reading frames from pOJ75 and pOJ74, respectively,
were constructed as follows. HindIII-NotI fragments har-
boring the coding sequences of pOJ74 and pOJ75 were
purified, blunt ended using Klenow Fragment, and
inserted into the HpaI site of the pLXSN plasmid [29],
encoding the retroviral transfer vector LXSN; the resulting
plasmids, pLPiT1SN and pLPiT2SN, respectively, were
verified by sequence analysis (Kjærgaard, M. M. and Ped-
ersen, L., unpublished work). The LMP [30] (Open Biosys-
tems, France) derived transfer vector, LMP-
MmPiT1shRNAmiR, was made by insertion of a shRNA
encoding sequence targeting murine PiT1: 5’TGCTGT
TGAC AGTGAGCGAA CCCATTGTAT TGTCGG
TGCA TAGTGAAGCC ACAGATGTAT GCACCGA-
CAA TACAATGGGT CTGCCTACTG CCTCGGA 3’
(bold being the target and complementary sequences for
mouse PiT1). The authenticity of the LMP-derived vector
was confirmed by sequence analysis. His-tagged FeLV-B
RBD was produced from a pCDNA3 vector encoding the
first 212 N-terminal amino acids of the SU of FeLV-B (G/
A) fused to a C-terminal His-tag via a short linker (Dreyer,
K. and Pedersen, L., unpublished work). C-terminally His-
tagged A-MLV RBD encoded by a FBASALF-derived vec-
tor has been described elsewhere [31].
Cells
The pre-osteoblastic murine cell line, MC3T3-E1 [22] (a
kind gift from Dr. H. Kodama) and derivatives of this
were cultured in Minimum Essential Medium alpha
(MEMa)( G i b c oB R L )s u p p l e m e n t e dw i t h1 0 %F B S
(Gibco BRL) and 1% Penicillin and Streptomycin (PS)
(Gibco BRL) (MEMa-FBS-PS). Only MC3T3-E1 cells
and derivatives of this cell line below the 5
th passage
were used for experiments. The murine fibroblastic cell
line, NIH3T3 (ATCC CRL-1658), and derivatives of this
were cultivated in Dulbecco’s Modified Eagle’sM e d i u m
(DMEM) (Gibco BRL) supplemented with 10% Newborn
Calf Serum (NCS) (Gibco BRL) and 1% PS (DMEM-
NCS-PS). The 293T-derived retroviral packaging cell
l i n e s ,P l a t i n i u mE c o( P l a t E )[ 3 2 ]a n dP h o e n i x ™Eco
(Orbigen) (http://www.stanford.edu/group/nolan/retro-
viral_systems/phx.html), and derivatives of the latter
were cultivated in DMEM-FBS-PS. A-MLV (4070A iso-
late) and GALV (SEATO) pseudotypes of the b-galactosi-
dase-encoding transfer vector G1BgSvN (GBN) [33] were
obtained from the producer cell lines, PA317-GBN
[29,34] and PG13-GBN [35], respectively. Both producer
cell lines were cultivated in DMEM-NCS-PS. Vectors
were harvested as supernatants from confluent producer
cells and vector containing supernatants were filtered
(0.45-μm pore size) and stored at −80°C until use. Dog
osteosarcoma D17 (ATCC CCL-183) cells were culti-
vated in MEMa-FBS-PS. All plastic ware used for cell
culture were from NUNC.
PiT1-knock-down in MC3T3-E1 cells
Phoenix™-Eco cells were seeded at 1 × 10
4 cells/cm
2 in
100-mm-diameter dishes and transfected with LMP or
LMP-MmPiT1shRNAmiR transfer vectors using the cal-
cium-phosphate DNA precipitation method [36]. Two
days after transfection, each 100-mm-diameter dish were
transferred to two T175 flasks and selected with 1.25 μg/
mL puromycin (Sigma-Aldrich) the first three days, and
thereafter cultivated in 0.5 μg/mL puromycin. The Phoe-
nix™-Eco-LMP and - LMP-MmPiT1shRNAmiR cells
were grown to confluence, media were changed to
MEMa-FBS-PS, and retroviral vector containing superna-
tants were harvested, filtrated (0.45-μmp o r es i z e ) ,a n d
stored at −80°C until use. MC3T3-E1 cells were seeded at
2.5 × 10
3 cells/cm
2, and vector-containing supernatants
supplemented with 2 μg/mL Polybrene (PB, Sigma-
Aldrich) were added 3 times to the cells over 2 days. The
cells were transferred to T175 flasks and selected with 4
μg/mL puromycin for 2 days before used in experiments.
Establishment of LPiT1SN, LPiT2SN, and LXSN carrying
MC3T3-E1 and NIH3T3 cells
Retroviral transfer vectors for transduction of MC3T3-E1
and NIH3T3 cells were produced in PlatE cells. PlatE cells
were seeded at 4 × 10
6 cells/dish in 100-mm-diameter
dishes in standard growth medium. The next day, the
media were changed to fresh media and the cells were
transfected with 30 μg of pLXSN, pLPiT1SN, or pLPi
T2SN using the calcium-phosphate DNA precipitation
method. The day after transfection, the media were chan-
ged to harvest media, and 24 hours later, vector containing
supernatants were harvested, filtrated (0.45-μm pore size),
a n de i t h e ru s e dd i r e c t l yo rs t o r e da t−80°C until use. A
second harvest was made after an additional 24 hours
using the same procedure. MC3T3-E1 cell populations
carrying LPiT1SN, LPiT2SN, or empty vector LXSN were
established and referred to as MC3T3-E1-LPiT1SN,
MC3T3-E1-LPiT2SN, and MC3T3-E1-LXSN, respectively.
NIH3T3 cell populations carrying LPiT1SN or empty
vector LXSN were established and referred to as NIH3T3-
LPiT1SN or NIH3T3-LXSN, respectively. The establish-
ment of these cells was done as follows. MC3T3-E1 and
NIH3T3 cells seeded at 6 × 10
3 cells/cm
2 in 60-mm-dia-
meter dishes in standard growth media were transduced
over a period of approximately 30 hours. Approximately
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dish of filtered (0.45 μm) retroviral vector containing
supernatants from Plat-E cells with 2 μg/mL PB. Addi-
tional transductions were carried out twice the following
day. The transduced cells were selected with 400 μg active
G418 per mL (Gibco BRL). The day after the last trans-
duction, each 60-mm-dish was passaged into two T175
flasks in standard growth medium, and 48 hours later,
400 μg/mL active G418 was added, and G418 resistant cell
populations established. The selected MC3T3-E1 cell
populations were frozen at −80°C for at least 24 hours
before their use in experiments.
Proliferation assay
Cells were seeded in 4-well plates in quadruplicates in
standard growth medium. At indicated days, the cells
were detached from the wells using Trypsin-EDTA (5 ×
T) diluted in PBS from a stock of 10× Trypsin-EDTA
(0.5% Trypsin, Gibco BRL), and re-suspended in 500 μL
standard growth medium. Aliquots were mixed 1:1 with
Trypan Blue Stain (Gibco BRL) and counted using a cell
counting chamber.
Cell cycle analysis
Cells were seeded in T25-flasks at 20,000 cells/cm
2. After
24 hours, the cells were detached using 5 × T, pelleted by
centrifugation, re-suspended in PBS, cooled on ice,
mixed 1:1 with ice-cold 99.9% ethanol, incubated at least
10 minutes on ice and used for staining or stored at 4°C
until staining. Staining was carried out by pelleting the
cells by centrifugation, re-suspending them in 1 mL PBS
containing 20 μg/mL RNase A followed by addition of
100 μL propidium iodide (1 mg/mL). The cells were then
analyzed by flow cytometry (FL2 channel) using a FACS-
Calibur flow cytometer (Becton Dickinson). CellQuest
software was used for acquisition. FlowJo software was
used for subtraction of aggregates and doublets [37] and
for data analysis employing the Watson-Pragmatic
model.
RBD binding assay
His-tagged RBDs were produced in 293T cells. Shortly,
293T cells were seeded at 4 × 10
6 cells/dish in 100-mm-
diameter dishes and transfected the following day with 15
μg His-tagged FeLV-B RBD or His-tagged A-MLV RBD
encoding expression plasmids together with 15 μg carrier
plasmid (pUC18) per dish using the calcium-phosphate
DNA precipitation method. At days 2 and 3 after transfec-
tion, RBD containing supernatants were harvested in stan-
dard growth medium, filtrated (0.45-μmp o r es i z e ) ,a n d
stored in aliquots at −80°C until use. For analysis of RBD
binding, cells were detached using 1 mM EDTA in PBS
and counted. Aliquots of 10
6 cells/sample were pelleted by
centrifugation for 5 minutes at 1200 rpm. The cell pellets
were re-suspended in 1 mL RBD-containing supernatant
or standard growth medium, as control, and incubated
20 minutes at 37°C. The cells were then washed 2× in 5%
FBS in PBS and incubated on ice with primary antibody,
Mouse-Anti-Penta-His (Qiagen), diluted 1:400 in 50 μL
5% FBS in PBS/sample for 45 minutes. Then the cells
were washed twice in ice-cold 5% FBS in PBS and incu-
bated for at least 45 minutes in the dark with 1 μg/sample
of PE-conjugated goat anti-mouse Ig (BD Pharma) diluted
in 300 μL 5% FBS in PBS. Finally, the cells were washed
1× in ice cold 5% FBS in PBS, fixed in 1% paraformalde-
hyde (Ampliqon) for 10 minutes at RT, washed 1× in PBS,
and re-suspended in 600 - 1000 μLP B S .T h es a m p l e s
were analyzed using the FL2-H channel on a FACSCalibur
flow cytometer. For data analysis, CellquestPro software
was used.
Transduction assay
MC3T3-E1-LXSN, -LPiT1SN, -LPiT2SN, NIH3T3-LXSN,
-LPiT1SN, and D17 cells were seeded in 24-well plates
with a density of 10
4 cells/cm
2 in standard growth media
and analyzed for their susceptibility to transduction with
GALV and A-MLV vector pseudotypes as previously
described for titer determination using dilution series of
vector-containing supernatants from PG13-GBN and
PA317-GBN producer cells, respectively [11]. The trans-
duction efficiency was evaluated as blue (b-galactosidase-
positive) colony forming units (CFUs).
qRT-PCR
Cells were lyzed on the plates and total RNA purified
using RNAqueous
®-4PCR kit (Applied Biosystems). The
RNA samples were DNase1 treated and after inactivation
of the DNase used directly for cDNA synthesis using the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) as recommended by the supplier. The sam-
ples were either stored at −20°C until use or used directly
for qRT-PCR analysis. For qRT-PCR analyses, the follow-
ing TaqMan
® Gene Expression Assays (Applied Biosys-
tems) were used according to the protocol: Mouse PiT1
(Mm00489378_m1), mouse PiT2 (Mm00660197_m1),
human PiT1 (Hs00965596_m1), human PiT2 (Hs0110
8472_m1) and, as endogenous control, mouse b-2-micro-
globulin (B2M)-VIC (Mm00437762_m1). The individual
qRT-PCR reactions contained 10 μLT a q M a n
® Fast
Universal PCR Master Mix ((Applied Biosystems), 1 μL
TaqMan
® Gene Expression Assay, 1 μLB 2 M ,a n d8μL
cDNA (approximately 10 ng). All samples were made in
triplicates for all genes analyzed. The efficiencies of each
set of primers were determined on dilution series of
cDNA and were used in calculations of relative gene
expression as described in ref. [38]. The PCR cycles
employed were: 95°C for 10 minutes, 40 cycles of 95°C
for 1 second, and 60°C for 20 seconds.
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Cells were seeded in 4-well plates, the next day, they were
washed in Pi-free DMEM (Gibco BRL) and hereafter incu-
bated 5 minutes in 37°C warm serum-free, Pi-free DMEM
containing KH2
32PO4 (900-1100 mCi/mmol, Perkin
Elmer) with or without added non-radioactive Pi.T h ee n d -
concentrations of Pi in the uptake experiments were 5 μM,
100 μM, or 300 μMP i. The cells were then washed 3× in
ice cold PBS or serum-free, Pi-free DMEM, and lyzed in
0.5% (w/v) SDS in PBS or in 0.5% (v/v) Triton X-100, and
2/3 of the lysate was mixed with 5 mL Ultima Gold Liquid
Scintillation Counter Cocktail (Perkin Elmer) or Optiphase
“Hisafe” 3 (Perkin Elmer) and measured in liquid scintilla-
tion counters. The differences in washing and lysis proce-
dures did not influence the results (unpubl. observation).
The rest of the sample was stored at −20°C until used for
protein determination using the BCA™ protein assay kit
(Pierce).
Soft agar assay
NIH3T3-LXSN and NIH3T3-LPiT1SN cells were pre-
incubated for two days in either standard growth medium
or DMEM-FBS-PS. Base agar was made by melting 1%
agar (SeaPlaque
®GTG
®Agarose, Lonza), cooling it to 40°C
in a water bath and mixing it with an equal volume of
40°C warm 2× DMEM (Gibco BRL) supplemented with
3.7 g NaHCO3 (MERCK), 2% PS, and 20% FBS (2 ×
DMEM/FBS) or 20% NCS (2 × DMEM/NCS); 0.5 mL
base agar was plated per well in 24-well plates and allowed
to set at 4°C. NIH3T3-LXSN or NIH3T3-LPiT1SN cells
grown in either DMEM-FBS-PS or DMEM-NCS-PS were
loosened with 5 × T and diluted to a concentration of 10
5
cells/mL, and 50 μL of the cells were mixed with 1 mL
melted 40°C 0.7% agar and 1 mL 40°C 2 × DMEM/FBS or
2 × DMEM/NCS, respectively, and 0.5 mL per well were
seeded on top of the solidified base agar containing
DMEM/FBS or DMEM/NCS, respectively. When the top
agar had set, 0.25 mL DMEM-NCS-PS or DMEM-FBS-PS
were added to each well. The dishes were incubated for 18
days at 37°C and 5% CO2. Colonies were stained by addi-
tion of 200 μL 0.005% Crystal Violet (MERCK) to each
well followed by 1 hour incubation at room temperature
before counting the colonies under a microscope.
Statistical analysis
The hypothesis that two mean values were identical was
tested by a two-tailed Student’s t-test; a p-value <0.05
was considered statistically significant.
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